Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / GLOBAL EX US HGH
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
5,911,788
-
Shares change
-
-244,486
-
Total reported value, excl. options
-
$128,404,050
-
Value change
-
-$5,375,264
-
Number of buys
-
35
-
Number of sells
-
-23
-
Price
-
$21.73
Significant Holders of INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) as of Q3 2021
66 filings reported holding PGHY - INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH as of Q3 2021.
INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,911,788 shares
.
Largest 10 shareholders include Whitcomb & Hess, Inc. (695,906 shares), Cerity Partners LLC (465,575 shares), CABOT WEALTH MANAGEMENT INC (434,379 shares), Essex LLC (374,410 shares), Kestra Advisory Services, LLC (322,958 shares), PFS INVESTMENTS INC. (307,116 shares), Legacy Capital Wealth Partners, LLC (266,044 shares), Sowell Financial Services LLC (203,292 shares), Advisory Alpha, LLC (201,433 shares), and FLOW TRADERS U.S. LLC (199,900 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.